Ageing and atherosclerosis: Mechanisms and therapeutic options
Next generation topoisomerase I inhibitors: Rationale and biomarker strategies
Quinolones as enhancers of camptothecin-induced cytotoxic and anti-topoisomerase I effects
Modulation of gold(III) porphyrin 1a-induced apoptosis by mitogen-activated protein kinase signaling pathways
TGF-β1 increases motility and αvβ3 integrin up-regulation via PI3K, Akt and NF-κB-dependent pathway in human chondrosarcoma cells
Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1®
Increased mitochondrial DNA copy-number in CEM cells resistant to delayed toxicity of 2′,3′-dideoxycytidine
Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure
JM91, a newly synthesized indoledione derivative, inhibits rat aortic vascular smooth muscle cells proliferation and cell cycle progression through inhibition of ERK1/2 and Akt activations
Caged agonist of P2Y1 and P2Y12 receptors for light-directed facilitation of platelet aggregation
Topical transduction of superoxide dismutase mediated by HIV-1 Tat protein transduction domain ameliorates 12- O -tetradecanoylphorbol-13-acetate (TPA)-induced inflammation in mice
Release of arachidonic acid induced by tumor necrosis factor-α in the presence of caspase inhibition: Evidence for a cytosolic phospholipase A2α-independent pathway
Differential effects of phorbol-13-monoesters on human immunodeficiency virus reactivation
Deoxyelephantopin inhibits cancer cell proliferation and functions as a selective partial agonist against PPARγ
Cyanidin 3-glucoside protects 3T3-L1 adipocytes against H2O2- or TNF-α-induced insulin resistance by inhibiting c-Jun NH2-terminal kinase activation
Acetaminophen normalizes glucose homeostasis in mouse models for diabetes
Lobeline effects on tonic and methamphetamine-induced dopamine release
Structure–activity relationship of coumarin derivatives on xanthine oxidase-inhibiting and free radical-scavenging activities
Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes
Note to readers
Corrigendum to “Synthesis of microtubule-interfering halogenated noscapine analogs that perturb mitosis in cancer cells followed by cell death” [Biochem. Pharmacol. 72 (4) (2006) 415–426],
In response to “Selective serotonin reuptake inhibitors—A new modality for the treatment of lymphoma/leukaemia?” by C. Schuster, et al. [Biochem. Pharmacol. 74 (9) 2007 1424–1435],
Reply to J. Gordon et al.